(HEIA) Heineken - Overview
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0000009165
Stock: Beer, Cider, Soft Drinks
Total Rating 36
Risk 67
Buy Signal -1.50
| Risk 5d forecast | |
|---|---|
| Volatility | 20.5% |
| Relative Tail Risk | -9.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.51 |
| Alpha | -11.65 |
| Character TTM | |
|---|---|
| Beta | -0.126 |
| Beta Downside | 0.075 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.50% |
| CAGR/Max DD | -0.30 |
Description: HEIA Heineken March 04, 2026
Heineken N.V. is a global brewer and cider producer. Its operations span Europe, the Americas, Africa, the Middle East, and Asia Pacific. The company also offers soft drinks.
The company manages a portfolio of over 40 brands, including Heineken, Amstel, and Tiger. This multi-brand strategy is common in the beverage sector to target diverse consumer preferences.
Beyond beverage production, Heineken engages in pub and bar rentals, wholesale distribution, and provides pub management and technical services. This vertically integrated approach can enhance control over distribution channels.
Heineken distributes its products to a wide range of clients, including retailers, wholesalers, distributors, bars, restaurants, clubs, cafes, and hotels. The company was founded in 1864 and is headquartered in Amsterdam, Netherlands. It operates as a subsidiary of Heineken Holding N.V.
For a deeper dive into Heinekens financial performance and market position, consider exploring its profile on ValueRay.
Headlines to watch out for
- Global beer consumption trends impact Heineken sales
- Raw material price volatility affects production costs
- Regulatory changes on alcohol sales pose market risks
- Emerging market growth drives volume expansion
- Currency fluctuations impact international revenue translation
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 2.49b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 5.43 > 1.0 |
| NWC/Revenue: -2.02% < 20% (prev -7.51%; Δ 5.50% < -1%) |
| CFO/TA 0.19 > 3% & CFO 10.52b > Net Income 2.49b |
| Net Debt (15.68b) to EBITDA (9.65b): 1.63 < 3 |
| Current Ratio: 0.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (560.6m) vs 12m ago -0.86% < -2% |
| Gross Margin: 22.33% > 18% (prev 0.11%; Δ 2.22k% > 0.5%) |
| Asset Turnover: 92.48% > 50% (prev 80.86%; Δ 11.61% > 0%) |
| Interest Coverage Ratio: 4.06 > 6 (EBITDA TTM 9.65b / Interest Expense TTM 1.30b) |
Altman Z'' 2.19
| A: -0.02 (Total Current Assets 12.89b - Total Current Liabilities 13.93b) / Total Assets 54.96b |
| B: 0.36 (Retained Earnings 19.75b / Total Assets 54.96b) |
| C: 0.09 (EBIT TTM 5.28b / Avg Total Assets 55.67b) |
| D: 0.48 (Book Value of Equity 16.59b / Total Liabilities 34.34b) |
| Altman-Z'' Score: 2.19 = BBB |
Beneish M -3.71
| DSRI: 0.83 (Receivables 4.19b/4.49b, Revenue 51.48b/45.60b) |
| GMI: 0.50 (GM 22.33% / 11.25%) |
| AQI: 0.93 (AQ_t 0.50 / AQ_t-1 0.54) |
| SGI: 1.13 (Revenue 51.48b / 45.60b) |
| TATA: -0.15 (NI 2.49b - CFO 10.52b) / TA 54.96b) |
| Beneish M-Score: -3.71 (Cap -4..+1) = AAA |
What is the price of HEIA shares?
As of March 22, 2026, the stock is trading at EUR 66.38 with a total of 1,729,992 shares traded.
Over the past week, the price has changed by -7.06%, over one month by -14.17%, over three months by -3.09% and over the past year by -12.29%.
Over the past week, the price has changed by -7.06%, over one month by -14.17%, over three months by -3.09% and over the past year by -12.29%.
Is HEIA a buy, sell or hold?
Heineken has no consensus analysts rating.
What are the forecasts/targets for the HEIA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 89.1 | 34.2% |
| Analysts Target Price | - | - |
HEIA Fundamental Data Overview March 21, 2026
Market Cap USD = 43.04b (37.54b EUR * 1.1464 EUR.USD)
P/E Trailing = 19.8402
P/E Forward = 13.8889
P/S = 1.3057
P/B = 2.1443
P/EG = 1.2951
Revenue TTM = 51.48b EUR
EBIT TTM = 5.28b EUR
EBITDA TTM = 9.65b EUR
Long Term Debt = 15.02b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.09b EUR (from shortTermDebt, last quarter)
Debt = 20.45b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.68b EUR (from netDebt column, last quarter)
Enterprise Value = 53.22b EUR (37.54b + Debt 20.45b - CCE 4.77b)
Interest Coverage Ratio = 4.06 (Ebit TTM 5.28b / Interest Expense TTM 1.30b)
EV/FCF = 8.87x (Enterprise Value 53.22b / FCF TTM 6.00b)
FCF Yield = 11.28% (FCF TTM 6.00b / Enterprise Value 53.22b)
FCF Margin = 11.66% (FCF TTM 6.00b / Revenue TTM 51.48b)
Net Margin = 4.84% (Net Income TTM 2.49b / Revenue TTM 51.48b)
Gross Margin = 22.33% ((Revenue TTM 51.48b - Cost of Revenue TTM 39.99b) / Revenue TTM)
Gross Margin QoQ = 12.93% (prev 34.87%)
Tobins Q-Ratio = 0.97 (Enterprise Value 53.22b / Total Assets 54.96b)
Interest Expense / Debt = 1.59% (Interest Expense 325.0m / Debt 20.45b)
Taxrate = 27.74% (491.0m / 1.77b)
NOPAT = 3.82b (EBIT 5.28b * (1 - 27.74%))
Current Ratio = 0.93 (Total Current Assets 12.89b / Total Current Liabilities 13.93b)
Debt / Equity = 1.14 (Debt 20.45b / totalStockholderEquity, last quarter 17.98b)
Debt / EBITDA = 1.63 (Net Debt 15.68b / EBITDA 9.65b)
Debt / FCF = 2.61 (Net Debt 15.68b / FCF TTM 6.00b)
Total Stockholder Equity = 18.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.47% (Net Income 2.49b / Total Assets 54.96b)
RoE = 13.34% (Net Income TTM 2.49b / Total Stockholder Equity 18.67b)
RoCE = 15.68% (EBIT 5.28b / Capital Employed (Equity 18.67b + L.T.Debt 15.02b))
RoIC = 14.12% (NOPAT 3.82b / Invested Capital 27.04b)
WACC = 3.93% (E(37.54b)/V(57.99b) * Re(5.45%) + D(20.45b)/V(57.99b) * Rd(1.59%) * (1-Tc(0.28)))
Discount Rate = 5.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.43%
[DCF] Terminal Value 85.54% ; FCFF base≈4.84b ; Y1≈4.48b ; Y5≈4.08b
[DCF] Fair Price = 191.4 (EV 122.81b - Net Debt 15.68b = Equity 107.14b / Shares 559.8m; r=5.90% [WACC]; 5y FCF grow -9.23% → 2.90% )
EPS Correlation: -18.65 | EPS CAGR: -65.52% | SUE: 0.0 | # QB: 0
Revenue Correlation: 54.51 | Revenue CAGR: 42.66% | SUE: -0.03 | # QB: 0
EPS current Year (2026-12-31): EPS=5.23 | Chg7d=+0.002 | Chg30d=+0.012 | Revisions Net=+1 | Growth EPS=+9.5% | Growth Revenue=-10.3%
EPS next Year (2027-12-31): EPS=5.65 | Chg7d=+0.002 | Chg30d=+0.004 | Revisions Net=-1 | Growth EPS=+7.9% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 2.9% (Discount Rate 7.9% - Earnings Yield 5.0%)
[Growth] Growth Spread = +1.1% (Analyst 4.0% - Implied 2.9%)
P/E Trailing = 19.8402
P/E Forward = 13.8889
P/S = 1.3057
P/B = 2.1443
P/EG = 1.2951
Revenue TTM = 51.48b EUR
EBIT TTM = 5.28b EUR
EBITDA TTM = 9.65b EUR
Long Term Debt = 15.02b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.09b EUR (from shortTermDebt, last quarter)
Debt = 20.45b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.68b EUR (from netDebt column, last quarter)
Enterprise Value = 53.22b EUR (37.54b + Debt 20.45b - CCE 4.77b)
Interest Coverage Ratio = 4.06 (Ebit TTM 5.28b / Interest Expense TTM 1.30b)
EV/FCF = 8.87x (Enterprise Value 53.22b / FCF TTM 6.00b)
FCF Yield = 11.28% (FCF TTM 6.00b / Enterprise Value 53.22b)
FCF Margin = 11.66% (FCF TTM 6.00b / Revenue TTM 51.48b)
Net Margin = 4.84% (Net Income TTM 2.49b / Revenue TTM 51.48b)
Gross Margin = 22.33% ((Revenue TTM 51.48b - Cost of Revenue TTM 39.99b) / Revenue TTM)
Gross Margin QoQ = 12.93% (prev 34.87%)
Tobins Q-Ratio = 0.97 (Enterprise Value 53.22b / Total Assets 54.96b)
Interest Expense / Debt = 1.59% (Interest Expense 325.0m / Debt 20.45b)
Taxrate = 27.74% (491.0m / 1.77b)
NOPAT = 3.82b (EBIT 5.28b * (1 - 27.74%))
Current Ratio = 0.93 (Total Current Assets 12.89b / Total Current Liabilities 13.93b)
Debt / Equity = 1.14 (Debt 20.45b / totalStockholderEquity, last quarter 17.98b)
Debt / EBITDA = 1.63 (Net Debt 15.68b / EBITDA 9.65b)
Debt / FCF = 2.61 (Net Debt 15.68b / FCF TTM 6.00b)
Total Stockholder Equity = 18.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.47% (Net Income 2.49b / Total Assets 54.96b)
RoE = 13.34% (Net Income TTM 2.49b / Total Stockholder Equity 18.67b)
RoCE = 15.68% (EBIT 5.28b / Capital Employed (Equity 18.67b + L.T.Debt 15.02b))
RoIC = 14.12% (NOPAT 3.82b / Invested Capital 27.04b)
WACC = 3.93% (E(37.54b)/V(57.99b) * Re(5.45%) + D(20.45b)/V(57.99b) * Rd(1.59%) * (1-Tc(0.28)))
Discount Rate = 5.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.43%
[DCF] Terminal Value 85.54% ; FCFF base≈4.84b ; Y1≈4.48b ; Y5≈4.08b
[DCF] Fair Price = 191.4 (EV 122.81b - Net Debt 15.68b = Equity 107.14b / Shares 559.8m; r=5.90% [WACC]; 5y FCF grow -9.23% → 2.90% )
EPS Correlation: -18.65 | EPS CAGR: -65.52% | SUE: 0.0 | # QB: 0
Revenue Correlation: 54.51 | Revenue CAGR: 42.66% | SUE: -0.03 | # QB: 0
EPS current Year (2026-12-31): EPS=5.23 | Chg7d=+0.002 | Chg30d=+0.012 | Revisions Net=+1 | Growth EPS=+9.5% | Growth Revenue=-10.3%
EPS next Year (2027-12-31): EPS=5.65 | Chg7d=+0.002 | Chg30d=+0.004 | Revisions Net=-1 | Growth EPS=+7.9% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 2.9% (Discount Rate 7.9% - Earnings Yield 5.0%)
[Growth] Growth Spread = +1.1% (Analyst 4.0% - Implied 2.9%)